Abstract 962: Mechanism-based drug combinations with the DNA-strand-breaking nucleoside analog CNDAC

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Cancer Research

• Publication date

  2011-04-15

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1158/1538-7445.AM2011-962
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Cytotoxic and radiosensitising effects of a novel thioredoxin reductase inhibitor in breast cancer

  2021cites this paper
• Repair of DNA damage induced by the novel nucleoside analogue CNDAG through homologous recombination

  2020cites this paper
• Targeting BRCA1/2 deficient ovarian cancer with CNDAC-based drug combinations

  2018cites this paper
• TDP1 is Critical for the Repair of DNA Breaks Induced by Sapacitabine, a Nucleoside also Targeting ATM- and BRCA-Deficient Tumors

  2017cites this paper
• Sapacitabine for cancer

  2012cites this paper